In latest blow to Moderna, FDA refuses to review Cambridge biotech firm’s new flu vaccine

The Food and Drug Administration last week refused to review Moderna’s application for its messenger RNA flu vaccine, in a ...

Aramis Biotechnologies and the Biologics Manufacturing Centre (BMC) Inc. announce the successful delivery of a seasonal influenza vaccine in development

CNW/ - Aramis Biotechnologies Inc. ("Aramis"), a Canadian company pioneering and a global leader in plant‑based bioproduction ...
Opinion
allAfrica.com on MSNOpinion

Building Health Systems for Africa's Vaccine Sovereignty, By Chinedu Moghalu and Nicaise Ndembi

Africa's engagement with global vaccine supply over the past five years has shown that access to vaccines and biologics is shaped less by goodwill or financing alone.Vaccine sovereignty in Africa is ...
PharmTech

Women in STEM: Unique Impacts in Rare Disease Development

Women in STEM bring diverse perspectives that are especially valuable in rare disease research. These conditions are complex and require innovative thinking. Attention to detail, empathy, and ...

Budget 2026: India’s push for global biopharma leadership

The FY26 Budget reinforces AI and digital transformation as core national priorities. We expect accelerated investment in ...
The Manila Times

Milestone Pharmaceuticals Appoints David Sandoval as General Counsel and Chief Compliance Officer

New appointment strengthens executive leadership commensurate with launch of CARDAMYST™ (etripamil) nasal spray ...